XML 48 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
3 Months Ended
Mar. 31, 2014
Stock-Based Compensation [Abstract]  
Stock-Based Compensation

Note 9 - Stock-Based Compensation

 

Stock Options

 

The Company has granted equity awards under several plans, two of which remain active. Under the 2005 Stock Incentive Plan (the "2005 Plan"), equity awards may be granted to officers, directors, employees, consultants and advisors to the Company and any present or future subsidiary. The 2005 Plan, approved in May 2005 and amended most recently in June 2013 by the Company's stockholders, currently authorizes the grant of equity awards for up to 22,312,192 shares of common stock, which included, at the time of approval of the 2005 Plan, a maximum 5,746,468 shares of common stock subject to stock options outstanding under the Company's 1995 Stock Option Plan (the "1995 Plan") that may revert to and become issuable under the 2005 Plan if such options expire or otherwise terminate unexercised. The Company will seek approval at its 2014 annual meeting of stockholders to increase the number of shares of common stock available for issuance under the 2005 Plan by 4,000,000 shares. The term of the Company's 1995 Plan has expired and no new awards will be made under the 1995 Plan; however, outstanding stock options remain in existence in accordance with their terms.

 

Under the 2005 Plan and the 1995 Plan, incentive stock options, having a maximum term of 10 years, can be or were granted at no less than 100% of the fair value of the Company's common stock at the time of grant and are generally exercisable over periods ranging from six months to four years. There is no minimum exercise price for non-statutory stock options.

 

Stock Options Awards

 

The following is a summary of option activity under the 2005 Plan and the 1995 Plan for the three months ended March 31, 2014:

 

    2005 Stock Incentive Plan     1995 Stock Option Plan  
    Stock Options     Weighted-Average Exercise Price     Stock Options     Weighted-Average Exercise Price  
Outstanding at January 1, 2014     11,788,100     $ 1.87       188,150     $ 5.04  
Granted     4,009,000     $ 6.03       -     $ -  
Exercised     (379,287 )   $ 2.00       (32,450 )   $ 4.81  
Canceled     (93,750 )   $ 2.60       (137,000 )   $ 5.97  
Outstanding at March 31, 2014     15,324,063     $ 2.95       18,700     $ 2.51  
Shares exercisable at March 31, 2014     5,586,387     $ 1.87       18,700     $ 2.51  
                                 
Shares available for grant at
March 31, 2014
    2,685,719                          

 

The fair value of stock options granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

   

Three Months Ended

March 31,

    2014   2013

Weighted-average Black-Scholes

fair value of stock options granted

  $2.63   $1.00
Risk-free interest rate   1.24%-2.22%   0.62%-1.34%
Dividend yield   0%   0%
Volatility   52.47%-67.93%   69.23%-73.72%
Expected term (in years)   4.04-6.96   4.06-7.05
Expected forfeiture rate   0%-23.15%   0%-23.15%

 

The aggregate intrinsic value and weighted-average remaining contractual term of stock options outstanding as of March 31, 2014 was approximately $30.3 million and 8.1 years, respectively. The aggregate intrinsic value and weighted-average remaining contractual term of stock options exercisable as of March 31, 2014 was approximately $15.0 million and 6.5 years, respectively. The aggregate intrinsic value represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2014. This amount is subject to change based on changes to the closing price of the Company's common stock. The aggregate intrinsic value of options exercised for the three months ended March 31, 2014 and 2013 was $1.4 million and less than $0.1 million, respectively.

 

Employee Stock Purchase Plan

 

The Company received approval at its 2013 annual meeting of stockholders to adopt an Employee Stock Purchase Plan (the "ESPP"), which authorized an aggregate of 2,000,000 shares of Common Stock to be purchased, which increases 5% on each anniversary of its adoption up to a maximum of 3,000,000 shares. The ESPP allows employees to purchase shares of Common Stock of the Company at each purchase date through payroll deductions of up to a maximum of 15% of their compensation, at 85% of the lesser of the market price of the shares at the time of purchase or the market price on the beginning date of an option period (or, if later, the date during the option period when the employee was first eligible to participate). At March 31, 2014, there were 1,811,176 shares available for issuance under the ESPP.

 

The ESPP is considered compensatory for financial reporting purposes. As such, the fair value of ESPP shares was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

 

    Three Months
Ended
March 31,
    2014
Weighted-average Black-Scholes fair value
of ESPP shares granted
 

$0.97-$1.79

Risk-free interest rate   0.11%-0.14%
Dividend yield   0%
Volatility   53.80%-67.57%
Expected term (in years)  

0.5-1.0

Expected forfeiture rate   5%

 

Restricted Stock Awards

 

Under the 2005 Plan, the Company has granted restricted stock awards subject to certain performance-based and/or time-based vesting conditions which, if not met, would result in forfeiture of the shares and reversal of any previously recognized related stock-based compensation expense.

 

The following is a summary of restricted stock awards activity for the three months ended March 31, 2014:

 

     

 

 

 

Number of

Shares

     

Per Share Weighted-Average Grant-Date

Fair Value

 
Outstanding and Unvested at January 1, 2014     16,667     $ 1.39  
Restricted stock granted     -     $ -  
Restricted stock vested     -     $ -  
Restricted stock forfeited     -     $ -  
Outstanding and Unvested at March 31, 2014     16,667     $ 1.39  

 

The Company recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

 

   

Three Months Ended

March 31,

 
    2014     2013  
Research and development   $ 524     $ 217  
General and administrative     516       266  
Total stock-based compensation expense   $ 1,040     $ 483  

 

As of March 31, 2014, there was approximately $11.6 million of total unrecognized compensation expense (net of estimated forfeitures) related to unvested options and restricted stock awards. This unrecognized compensation expense is expected to be recognized over a weighted-average period of 1.7 years. This estimate does not include the impact of other possible stock-based awards that may be made during future periods.